Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, and accelerating timelines.

AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

CEO Ritik Malhotra is leveraging Savvy Wealth's Fidelity partnership in offers to Commonwealth advisors, alongside ...

The XGBoost model (XGB3) was used for task 3, which comprises a total of seven models. The current study considered data from individuals who resided in Ontario, were diagnosed with IBD ...

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

Major stock indexes held firm in the stock market today after three days of bullish gains. Tesla spiked 9% and Nvidia led the ...

Breaking away from a commoditized and homogenous IBD model, Cetera offers financial professionals and institutions the latest solutions, support, and services to grow, scale, or transition with a ...

Dallas-based broker-dealer Prospera Financial Services has bought Cutter & Co., a St. Louis broker-dealer with $2 billion in client assets, according to a press release. The acquisition is intended to ...

Tesla's upcoming earnings report will include a company update, addressing key investor concerns about affordable EVs, ...

Cetera Financial Group, the premier financial advisor Wealth Hub, announced that experienced financial advisor Jonathan Bulman has transferred from Osaic to the unique Summit Financial Networks region ...

Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...